Health And Medicine

An uncommon mutation of the BRAF gene in melanoma patients has been found to respond to a specific drug therapy, providing a rationale for routine screening and therapy in melanoma patients who harbor the BRAF L597 mutation. Read More

A protein linked to aggressive bladder cancers could point to new strategies for treatment or prevention. Read More

Targeting immune system proteins may keep prostate cancer from spreading to bone. Read More

iStock High consumption of vitamin E either from diet or vitamin supplements may lower the risk of liver cancer, according to a study published July 17 in the Journal of the National Cancer Institute. The study was conducted by investigators from the Shanghai Cancer Institute,… Read More

Vanderbilt researchers have been selected to receive a national grant as part of a push to gauge the coming impact of the Affordable Care Act (ACA). Read More

As more and better treatments are developed for heart disease, it is becoming more difficult to safely manage care as patients return home from the hospital. A new study led by Vanderbilt researchers highlights growing concern that the period after hospital discharge is a risky time, especially for cardiac patients. Read More

Understanding how antibodies with long “loops” form may be important for HIV vaccine development. Read More

When discovering drugs for brain disorders, it’s important to test the candidates in multiple ways to avoid advancing those with restricted physiological effects. Read More

Chin Chiang, Ph.D., professor of Cell and Developmental Biology and member of the Vanderbilt-Ingram Cancer Center faculty, has been awarded a $200,000 grant to study an aggressive form of childhood cancer. Read More

Researchers at Vanderbilt University Medical Center are leading an international clinical trial to examine the functional benefits of a combined therapy to treat acute ischemic stroke. Read More

Vanderbilt University’s largest single government research grant, its Clinical and Translational Science Award (CTSA), has been renewed for another five years for $46 million. Read More

An experimental drug that activates T-cells and promotes an immune response to fight tumors has shown promising early results in patients with kidney cancer, melanoma and non-small cell lung cancer. Leora Horn, M.D. Vanderbilt-Ingram Cancer Center investigators Leora Horn, M.D., Jeffrey Sosman, M.D., and researchers from several other cancer… Read More

A genetic variant may help keep an individual’s “good” cholesterol in check. Read More

Obesity increases the risk of acute kidney injury following cardiac surgery, according to a Vanderbilt study published in the Journal of the American Society of Nephrology. Read More

New findings point to brain circuitry that communicates about the body’s nutritional status and regulates how nutrients are mobilized. Read More

Intensive care units at Vanderbilt University Hospital and the Monroe Carell Jr. Children’s Hospital at Vanderbilt are achieving exceptionally low rates of central line-associated blood stream infection (CLABSI), according to a report released this week by the Tennessee Department of Health. Read More

Low oxygen – and the activation of factors that respond to this situation – may be protective in chronic kidney disease. Read More

Research reveals clues to HIV risk in Chinese men who have sex with other men. Read More

A grant from the Tennessee Department of Education will allow the Vanderbilt Kennedy Center’s Treatment and Research Institute for Autism Spectrum Disorders to conduct statewide autism training for Tennessee's schools. Read More

Study finds no evidence of increased mitochondrial mutations in the children of women treated with radiation for cancer. Read More